Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Neoantigen Targeted Therapies Market Size Analysis from 2022 to 2027

1.5.1 Global Neoantigen Targeted Therapies Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Neoantigen Targeted Therapies Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Neoantigen Targeted Therapies Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Neoantigen Targeted Therapies Industry Impact

Chapter 2 Global Neoantigen Targeted Therapies Competition by Types, Applications, and Top Regions and Countries

2.1 Global Neoantigen Targeted Therapies (Volume and Value) by Type

2.1.1 Global Neoantigen Targeted Therapies Consumption and Market Share by Type (2016-2021)

2.1.2 Global Neoantigen Targeted Therapies Revenue and Market Share by Type (2016-2021)

2.2 Global Neoantigen Targeted Therapies (Volume and Value) by Application

2.2.1 Global Neoantigen Targeted Therapies Consumption and Market Share by Application (2016-2021)

2.2.2 Global Neoantigen Targeted Therapies Revenue and Market Share by Application (2016-2021)

2.3 Global Neoantigen Targeted Therapies (Volume and Value) by Regions

2.3.1 Global Neoantigen Targeted Therapies Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Neoantigen Targeted Therapies Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Neoantigen Targeted Therapies Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Neoantigen Targeted Therapies Consumption by Regions (2016-2021)

4.2 North America Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

4.10 South America Neoantigen Targeted Therapies Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Neoantigen Targeted Therapies Market Analysis

5.1 North America Neoantigen Targeted Therapies Consumption and Value Analysis

5.1.1 North America Neoantigen Targeted Therapies Market Under COVID-19

5.2 North America Neoantigen Targeted Therapies Consumption Volume by Types

5.3 North America Neoantigen Targeted Therapies Consumption Structure by Application

5.4 North America Neoantigen Targeted Therapies Consumption by Top Countries

5.4.1 United States Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

5.4.2 Canada Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

5.4.3 Mexico Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 6 East Asia Neoantigen Targeted Therapies Market Analysis

6.1 East Asia Neoantigen Targeted Therapies Consumption and Value Analysis

6.1.1 East Asia Neoantigen Targeted Therapies Market Under COVID-19

6.2 East Asia Neoantigen Targeted Therapies Consumption Volume by Types

6.3 East Asia Neoantigen Targeted Therapies Consumption Structure by Application

6.4 East Asia Neoantigen Targeted Therapies Consumption by Top Countries

6.4.1 China Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

6.4.2 Japan Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

6.4.3 South Korea Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 7 Europe Neoantigen Targeted Therapies Market Analysis

7.1 Europe Neoantigen Targeted Therapies Consumption and Value Analysis

7.1.1 Europe Neoantigen Targeted Therapies Market Under COVID-19

7.2 Europe Neoantigen Targeted Therapies Consumption Volume by Types

7.3 Europe Neoantigen Targeted Therapies Consumption Structure by Application

7.4 Europe Neoantigen Targeted Therapies Consumption by Top Countries

7.4.1 Germany Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.2 UK Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.3 France Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.4 Italy Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.5 Russia Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.6 Spain Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.7 Netherlands Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.8 Switzerland Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

7.4.9 Poland Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 8 South Asia Neoantigen Targeted Therapies Market Analysis

8.1 South Asia Neoantigen Targeted Therapies Consumption and Value Analysis

8.1.1 South Asia Neoantigen Targeted Therapies Market Under COVID-19

8.2 South Asia Neoantigen Targeted Therapies Consumption Volume by Types

8.3 South Asia Neoantigen Targeted Therapies Consumption Structure by Application

8.4 South Asia Neoantigen Targeted Therapies Consumption by Top Countries

8.4.1 India Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

8.4.2 Pakistan Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Neoantigen Targeted Therapies Market Analysis

9.1 Southeast Asia Neoantigen Targeted Therapies Consumption and Value Analysis

9.1.1 Southeast Asia Neoantigen Targeted Therapies Market Under COVID-19

9.2 Southeast Asia Neoantigen Targeted Therapies Consumption Volume by Types

9.3 Southeast Asia Neoantigen Targeted Therapies Consumption Structure by Application

9.4 Southeast Asia Neoantigen Targeted Therapies Consumption by Top Countries

9.4.1 Indonesia Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

9.4.2 Thailand Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

9.4.3 Singapore Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

9.4.4 Malaysia Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

9.4.5 Philippines Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

9.4.6 Vietnam Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

9.4.7 Myanmar Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 10 Middle East Neoantigen Targeted Therapies Market Analysis

10.1 Middle East Neoantigen Targeted Therapies Consumption and Value Analysis

10.1.1 Middle East Neoantigen Targeted Therapies Market Under COVID-19

10.2 Middle East Neoantigen Targeted Therapies Consumption Volume by Types

10.3 Middle East Neoantigen Targeted Therapies Consumption Structure by Application

10.4 Middle East Neoantigen Targeted Therapies Consumption by Top Countries

10.4.1 Turkey Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.3 Iran Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.5 Israel Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.6 Iraq Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.7 Qatar Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.8 Kuwait Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

10.4.9 Oman Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 11 Africa Neoantigen Targeted Therapies Market Analysis

11.1 Africa Neoantigen Targeted Therapies Consumption and Value Analysis

11.1.1 Africa Neoantigen Targeted Therapies Market Under COVID-19

11.2 Africa Neoantigen Targeted Therapies Consumption Volume by Types

11.3 Africa Neoantigen Targeted Therapies Consumption Structure by Application

11.4 Africa Neoantigen Targeted Therapies Consumption by Top Countries

11.4.1 Nigeria Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

11.4.2 South Africa Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

11.4.3 Egypt Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

11.4.4 Algeria Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

11.4.5 Morocco Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 12 Oceania Neoantigen Targeted Therapies Market Analysis

12.1 Oceania Neoantigen Targeted Therapies Consumption and Value Analysis

12.2 Oceania Neoantigen Targeted Therapies Consumption Volume by Types

12.3 Oceania Neoantigen Targeted Therapies Consumption Structure by Application

12.4 Oceania Neoantigen Targeted Therapies Consumption by Top Countries

12.4.1 Australia Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

12.4.2 New Zealand Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 13 South America Neoantigen Targeted Therapies Market Analysis

13.1 South America Neoantigen Targeted Therapies Consumption and Value Analysis

13.1.1 South America Neoantigen Targeted Therapies Market Under COVID-19

13.2 South America Neoantigen Targeted Therapies Consumption Volume by Types

13.3 South America Neoantigen Targeted Therapies Consumption Structure by Application

13.4 South America Neoantigen Targeted Therapies Consumption Volume by Major Countries

13.4.1 Brazil Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.2 Argentina Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.3 Columbia Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.4 Chile Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.5 Venezuela Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.6 Peru Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

13.4.8 Ecuador Neoantigen Targeted Therapies Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Neoantigen Targeted Therapies Business

14.1 Bavarian Nordic

14.1.1 Bavarian Nordic Company Profile

14.1.2 Bavarian Nordic Neoantigen Targeted Therapies Product Specification

14.1.3 Bavarian Nordic Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Neon Therapeutics

14.2.1 Neon Therapeutics Company Profile

14.2.2 Neon Therapeutics Neoantigen Targeted Therapies Product Specification

14.2.3 Neon Therapeutics Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Immunicum

14.3.1 Immunicum Company Profile

14.3.2 Immunicum Neoantigen Targeted Therapies Product Specification

14.3.3 Immunicum Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Genocea Biosciences

14.4.1 Genocea Biosciences Company Profile

14.4.2 Genocea Biosciences Neoantigen Targeted Therapies Product Specification

14.4.3 Genocea Biosciences Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 MediGene

14.5.1 MediGene Company Profile

14.5.2 MediGene Neoantigen Targeted Therapies Product Specification

14.5.3 MediGene Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Gradalis

14.6.1 Gradalis Company Profile

14.6.2 Gradalis Neoantigen Targeted Therapies Product Specification

14.6.3 Gradalis Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Iovance Biotherapeutics

14.7.1 Iovance Biotherapeutics Company Profile

14.7.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Product Specification

14.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Immunovative Therapies

14.8.1 Immunovative Therapies Company Profile

14.8.2 Immunovative Therapies Neoantigen Targeted Therapies Product Specification

14.8.3 Immunovative Therapies Neoantigen Targeted Therapies Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Neoantigen Targeted Therapies Market Forecast (2022-2027)

15.1 Global Neoantigen Targeted Therapies Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Neoantigen Targeted Therapies Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Neoantigen Targeted Therapies Value and Growth Rate Forecast (2022-2027)

15.2 Global Neoantigen Targeted Therapies Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Neoantigen Targeted Therapies Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Neoantigen Targeted Therapies Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Neoantigen Targeted Therapies Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Neoantigen Targeted Therapies Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Neoantigen Targeted Therapies Consumption Forecast by Type (2022-2027)

15.3.2 Global Neoantigen Targeted Therapies Revenue Forecast by Type (2022-2027)

15.3.3 Global Neoantigen Targeted Therapies Price Forecast by Type (2022-2027)

15.4 Global Neoantigen Targeted Therapies Consumption Volume Forecast by Application (2022-2027)

15.5 Neoantigen Targeted Therapies Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology